1-9 of 9
Vesa Juvonen
Close
Sort by
Journal Articles

Value of Flow Cytometry for MRD-Based Relapse Prediction in B-Cell Precursor Acute Lymphoblastic Leukemia in a Multi-Center Setting

Signe Modvig, MD PhD, Hans Madsen, Helene Hallböök, MD PhD, Sanna M. Siitonen, MD PhD, Liv T. N. Osnes, MD PhD, Susanne Rosthøj, PhD, Anne Tierens, MD PhD, Vesa Juvonen, PhD, Helen Vålerhaugen, Magnus Hultdin, MD PhD, Mats Ehinger, MD PhD, Anna Porwit, MD PhD, Reda Matuzeviciene, MD PhD, Mindaugas Stoskus, M Marincevic, PhD, Aili Lilleorg, PhD, Mervi Taskinen, MD PhD, Nina Toft, MD PhD, Ólafur Gísli Jónsson, MD PhD, Kaie Pruunsild, MD, Goda Elizabeta Vaitkeviciene, MD PhD, Kim Vettenranta, MD PhD, Bendik Lund, MD PhD, Jonas Abrahamsson, Kjeld Schmiegelow, Professor MD DMSc., Hanne Vibeke Marquart, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2755.
https://doi.org/10.1182/blood-2019-122311
Published: 2019
Journal Articles

MLL-USP2 : An Underestimated New Entity of MLL -Rearranged Leukemia Identified By NGS Analysis

Claus Meyer, PhD, Bruno Lopes, PhD, Aurélie Caye-Eude, PharmD, Hélène Cavé, PharmD, PhD, Chloé Arfeuille, PhD, Rosemary Sutton, PhD, Nicola Venn, BSc, Patrizia Larghero, PhD, Seung Hwan Oh, MD, Grigory Tsaur, MD PhD, Marketa Zaliova, Jan Zuna, Vesa Juvonen, PhD, Renate Panzer-Grümayer, MD, Grazia Fazio, PhD, Giovanni Cazzaniga, PhD, Mariana Emerenciano, PhD, Rolf Marschalek, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3920.
https://doi.org/10.1182/blood-2018-99-112594
Published: 2018
Journal Articles

Patients with Chronic Lymphocytic Leukemia Belonging to the B-Cell Receptor Stereotypy Subset #2 Have Long Progression Free Survival after Chemo- or Chemoimmunotherapy in the HOVON68 Trial

Fie Juhl Vojdeman, MD, Lone Bredo Pedersen, Doreen Te Raa, MD PhD, Vesa Juvonen, PhD, Yvette Norden, Geir Erland Tjønnfjord, MD DMsc, Eva Kimby, Maija Itälä-Remes, MD PhD, Anton W Langerak, Ludo M. Evers, Thorsten Zenz, MD, Marinus H.J. Van Oers, MD PhD, Christian H. Geisler, MD PhD, Arnon P. Kater, MD, Carsten Utoft Niemann, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4312.
https://doi.org/10.1182/blood.V130.Suppl_1.4312.4312
Published: 2017
Journal Articles

Flow Cytometry Based MRD Monitoring Is an Accurate Risk Stratification Tool in Acute T-Lymphoblastic Leukemia

Signe Modvig, MD PhD, Hans O Madsen, Sanna M. Siitonen, MD PhD, Susanne Rosthøj, PhD, Vesa Juvonen, PhD, Liv T. N. Osnes, MD PhD, Helen Vålerhaugen, Magnus Hultdin, MD PhD, M Marincevic, PhD, Reda Matuzeviciene, MD PhD, Mindaugas Stoskus, Aili Lilleorg, PhD, Nina Toft, MD PhD, Ólafur G. Jónsson, MD, Kjeld Schmiegelow, MD, Hanne Vibeke Marquart, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 372.
https://doi.org/10.1182/blood.V130.Suppl_1.372.372
Published: 2017
Journal Articles

Interferon Alpha Treated Patients with Chronic Myeloid Leukemia (CML) In Prolonged Complete Remission Have Increased Numbers of NK-Cells and Clonal Gamma-Delta T-Cells, and a Distinct Plasma Cytokine Profile.

Anna Kreutzman, MSc, Peter Rohon, MD, Edgar Faber, MD, PhD, Karel Indrak, MD, PhD, Vesa Juvonen, PhD, Veli Kairisto, MD, PhD, Jaroslava Voglova, MD, Marjatta Sinisalo, MD, PhD, Emilia Flochova, MD, PhD, Petteri Arstila, MD, PhD, Kimmo Porkka, MD, PhD, Satu Mustjoki, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1201.
https://doi.org/10.1182/blood.V116.21.1201.1201
Published: 2010
Journal Articles

Mono/oligoclonal T and NK cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy

Clinical Trials & Observations
Anna Kreutzman, Vesa Juvonen, Veli Kairisto, Marja Ekblom, Leif Stenke, Ruth Seggewiss, Kimmo Porkka, Satu Mustjoki
Journal: Blood
Blood (2010) 116 (5): 772–782.
https://doi.org/10.1182/blood-2009-12-256800
Published: 2010
Journal Articles

Mono/Oligoclonal T and NK Cells Are Common in Philadelphia Chromosome Positive (Ph+) Leukemia Patients at Diagnosis and Expand During Successful Tyrosine Kinase Inhibitor Therapy.

Anna Kreutzman, MSc, Vesa Juvonen, PhD, Veli Kairisto, MD, PhD, Marja Ekblom, MD, PhD, Leif Stenke, MD, PhD, Ruth Seggewiss, MD, Kimmo Porkka, MD, PhD, Satu Mustjoki, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 856.
https://doi.org/10.1182/blood.V114.22.856.856
Published: 2009
Journal Articles

Clonal Expansion of T/NK-Cells during Tyrosine Kinase Inhibitor Dasatinib Therapy

Satu Mustjoki, MD, PhD, Marja Ekblom, MD, PhD, T. Petteri Arstila, MD, PhD, Ingunn Dybedal, MD, PhD, PK Epling- Burnette, PhD, Felix Garzon, MD, PhD, Tobias Gedde-Dahl, MD, PhD, Sari Hernesniemi, MSc, Henrik Hjorth-Hansen, MD, PhD, Martin Hoglund, MD, PhD, Vesa Juvonen, PhD, Veli Kairisto, MD, PhD, Panu Kovanen, MD, PhD, Anna Kreutzman, MSc, Tuisku Laurinolli, Jane Liesveld, MD, Ronald Paquette, MD, Javier Pinilla, MD, PhD, Auvo Rauhala, MD, PhD, Neil Shah, MD, PhD, Bengt Simonsson, MD, PhD, Marjatta Sinisalo, MD, PhD, Juan Luis Steegmann, MD, PhD, Leif Stenke, MD, PhD, Jukka Vakkila, MD, PhD, Kimmo Porkka, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 573.
https://doi.org/10.1182/blood.V112.11.573.573
Published: 2008
Journal Articles

Nordic CML Study Group Quality and Standardization Rounds for Quantitative RT-PCR of BCR-ABL To Facilitate Reporting on the International Scale.

Hans Boström, MD, PhD, Tuija Lundan, M.Sc., Morten Tolstrup Andersen, M.Sc., Gisela Barbany, MD, Ph.D, Thoas Fioretos, MD, Ph.D, Irina Golovleva, Ph.D, Jon Jonasson, MD, Ph.D, Vesa Juvonen, Ph.D, Mikael Lindlöf, Ph.D, Mats Irgen Olsen, MD, Niels Pallisgaard, Ph.D, Eeva-Riitta Savolainen, MD, Ph.D, Marie Schaffer, MD, Ph.D, Aleksandra Silye, Henrik Hjorth-Hansen, MD, Ph.D, Magnus K. Magnusson, MD, Ph.D, Johann Lanng Nielsen, MD, Ph.D, Kimmo Porkka, MD, Ph.D, Bengt Simonsson, MD, Ph.D, Veli Kairisto, MD
Journal: Blood
Blood (2007) 110 (11): 4559.
https://doi.org/10.1182/blood.V110.11.4559.4559
Published: 2007